Lyzín

Pôsobí na: zachovanie celkového zdravia, imunitu, alergie

Lyzín je esenciálna aminokyselina, ktorá sa vo výživových doplnkoch bežne spája s vitamínom C. Skúma sa jeho využitie pri potláčaní symptómov herpesu, pretože jeho prítomnosť zabraňuje vírusu H. simplex vo využití arginínu, ktorý potrebuje na replikáciu.

Užívanie

Pre potlačenie symptómov herpesu sa odporúča užiť 2 g denne. Dávka sa užíva
rozdelená na menšie dávky spolu s jedlom. Užívanie arginínu je v tomto období kontraproduktívne. Ak je strava upravená tak, aby sa zvýšil príjem lyzínu, tak je potrebné kontrolovať príjem arginínu.

Medicínske upozornenie!

Literatúra

  1. Mirmiranpour H et al.. The Preventive Effect of L-Lysine on Lysozyme Glycation in Type 2 Diabetes. Acta Med Iran. (2016)
  2. Flodin NW. The metabolic roles, pharmacology, and toxicology of lysine. J Am Coll Nutr. (1997)
  3. FAO/WHO/UNU Expert Consultation. Protein and amino acid requirements in human nutrition.
  4. Gahl MJ et al.. Use of a four-parameter logistic equation to evaluate the response of growing rats to ten levels of each indispensable amino acid. J Nutr. (1991)
  5. Said AK, Hegsted DM, Hayes KC. Response of adult rats to deficiencies of different essential amino acids. Br J Nutr. (1974)
  6. Claeys WL, De Vleeschouwer K, Hendrickx ME. Effect of amino acids on acrylamide formation and elimination kinetics. Biotechnol Prog. (2005)
  7. Gao S et al.. Amino acid facilitates absorption of copper in the Caco-2 cell culture model. Life Sci. (2014)
  8. Bertinato J et al.. l-Lysine supplementation does not affect the bioavailability of copper or iron in rats. J Trace Elem Med Biol. (2016)
  9. Mitchell GV, Jenkins MY. Effect of excess L-lysine on rat growth and on plasma and tissue concentrations of copper, iron and zinc. J Nutr Sci Vitaminol (Tokyo). (1983)
  10. Aoyagi S, Baker DH. Copper-amino acid complexes are partially protected against inhibitory effects of L-cysteine and L-ascorbic acid on copper absorption in chicks. J Nutr. (1994)
  11. Rabiansky PA et al.. Evaluating copper lysine and copper sulfate sources for heifers. J Dairy Sci. (1999)
  12. Apgar GA, Kornegay ET. Mineral balance of finishing pigs fed copper sulfate or a copper-lysine complex at growth-stimulating levels. J Anim Sci. (1996)
  13. Kegley EB, Spears JW. Bioavailability of feed-grade copper sources (oxide, sulfate, or lysine) in growing cattle. J Anim Sci. (1994)
  14. O’Kane RL et al.. Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+. Am J Physiol Endocrinol Metab. (2006)
  15. White MF, Gazzola GC, Christensen HN. Cationic amino acid transport into cultured animal cells. I. Influx into cultured human fibroblasts. J Biol Chem. (1982)
  16. Closs EI et al.. Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide. (1997)
  17. Carter BW Jr, Chicoine LG, Nelin LD. L-lysine decreases nitric oxide production and increases vascular resistance in lungs isolated from lipopolysaccharide-treated neonatal pigs. Pediatr Res. (2004)
  18. Wass C et al.. L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study. BMC Med. (2011)
  19. Jafarnejad A et al.. The improvement effect of L-Lys as a chemical chaperone on STZ-induced diabetic rats, protein structure and function. Diabetes Metab Res Rev. (2008)
  20. Unni US et al.. The effect of a controlled 8-week metabolic ward based lysine supplementation on muscle function, insulin sensitivity and leucine kinetics in young men. Clin Nutr. (2012)
  21. Younus H, Anwar S. Prevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complication. Int J Health Sci (Qassim). (2016)
  22. William J. Welch, C. Randell Brown. Influence of molecular and chemical chaperones on protein folding. Cell Stress Chaperones. (1996)
  23. Tankersley RW Jr.. Amino Acid Requirements of Herpes Simplex Virus in Human Cells. J Bacteriol. (1964)
  24. Griffith RS, DeLong DC, Nelson JD. Relation of arginine-lysine antagonism to herpes simplex growth in tissue culture. Chemotherapy. (1981)
  25. Simon CA et al.. Failure of lysine in frequently recurrent herpes simplex infection. Arch Dermatol. (1985)
  26. DiGiovanna JJ, Blank H. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Arch Dermatol. (1984)
  27. Griffith RS et al.. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica. (1987)
  28. McCune MA. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis. (1984)
  29. Thein DJ, Hurt WC. Lysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis. Oral Surg Oral Med Oral Pathol. (1984)
  30. Milman N, Scheibel J, Jessen O. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. Acta Derm Venereol. (1980)
  31. Isidori A, Lo Monaco A, Cappa M. A study of growth hormone release in man after oral administration of amino acids. Curr Med Res Opin. (1981)
  32. Corpas E, et al. Oral arginine-lysine does not increase growth hormone or insulin-like growth factor-I in old men. J Gerontol. (1993)
  33. Fogelholm GM, et al. Low-dose amino acid supplementation: no effects on serum human growth hormone and insulin in male weightlifters. Int J Sport Nutr. (1993)
  34. Dawson-Hughes B et al.. Comparative effects of oral aromatic and branched-chain amino acids on urine calcium excretion in humans. Osteoporos Int. (2007)
  35. Busque SM et al.. L-type amino acids stimulate gastric acid secretion by activation of the calcium-sensing receptor in parietal cells. Am J Physiol Gastrointest Liver Physiol. (2005)
  36. Arthur D. Conigrave et al.. L-Amino acid sensing by the extracellular Ca2+-sensing receptor. PNAS. (1999)
  37. Bihuniak JD et al.. Supplementing a low-protein diet with dibasic amino acids increases urinary calcium excretion in young women. J Nutr. (2014)
  38. Civitelli R et al.. Dietary L-lysine and calcium metabolism in humans. Nutrition. (1992)
  39. Rubin AL et al.. The use of L-lysine monomydrochloride in combination with mercurial diuretics in the treatment of refractory fluid retention. Circulation. (1960)
  40. Lasser RP et al.. L-lysine monohydrochloride. A clinical study of its action as a chloruretic acidifying adjuvant to mercurial diuretics. N Engl J Med. (1960)
  41. Hevia et al.. Serum lipids of rats fed excess L-lysine and different carbohydrates. J Nutr. (1980)